Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey

Demirci, UmutGokmen, ErhanEralp, YesimGunduz, SeydaGoksu, Sema SezginKorkmaz, TanerKostek, Osman2024-06-122024-06-1220200008-54721538-7445https://doi.org/10.1158/1538-7445.SABCS19-P5-11-19https://hdl.handle.net/20.500.14551/2588142nd Annual San Antonio Breast Cancer Symposium -- DEC 09-14, 2019 -- San Antonio, TX[Abstract Not Available]en10.1158/1538-7445.SABCS19-P5-11-19info:eu-repo/semantics/closedAccess[No Keywords]Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in TurkeyConference Object804Q1WOS:000527012503011